Ascentage Pharma Group International (NASDAQ:AAPG) Raised to Strong-Buy at Citigroup

Ascentage Pharma Group International (NASDAQ:AAPG) was upgraded by Citigroup to a “strong-buy” rating in a report issued on Wednesday, Zacks reports.

Several other analysts also recently issued reports on the company. JPMorgan Chase & Co. dropped their price target on Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday, October 8th. William Blair initiated coverage on Ascentage Pharma Group International in a research report on Friday. They set an “outperform” rating for the company. Citizens Jmp initiated coverage on Ascentage Pharma Group International in a report on Tuesday. They set a “market outperform” rating and a $35.00 price objective for the company. Finally, BTIG Research reissued a “buy” rating and issued a $48.00 target price on shares of Ascentage Pharma Group International in a research report on Friday, August 21st. Three investment analysts have rated the stock with a Strong Buy rating and eleven have given a Buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $43.90.

Ascentage Pharma Group International Price Performance

Shares of AAPG stock opened at $14.69 on Wednesday. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.18 and a current ratio of 1.22. The company’s 50 day moving average price is $16.55 and its two-hundred day moving average price is $19.11. Ascentage Pharma Group International has a 52 week low of $14.45 and a 52 week high of $37.50.

Ascentage Pharma Group International (NASDAQ:AAPG) last issued its quarterly earnings data on Wednesday, August 19th. The company reported ($0.65) EPS for the quarter. The company had revenue of $22.24 million for the quarter. Equities research analysts forecast that Ascentage Pharma Group International will post -2.42 earnings per share for the current year.

About Ascentage Pharma Group International

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.